The results demonstrated that the CD117+CD44+CSC vaccine not only markedly decreased the CD117+CD44+CSC population, but also reduced ALDH-positive cell population in SKOV3 ovarian cancer tissues from the vaccinated nude mice compared with the mice vaccinated with other control vaccines. Here, CD44 is linked to ovarian cancer.